Suppr超能文献

用三种不同细胞遗传学工具估算五名放射事故受害者所受的生物剂量。

Estimation of the biological dose received by five victims of a radiation accident using three different cytogenetic tools.

机构信息

Department of Radiation Medicine and Clinical Hematology, The 307th Hospital, Beijing, PR China.

出版信息

Mutat Res. 2013 Feb 18;751(1):66-72. doi: 10.1016/j.mrgentox.2012.11.005. Epub 2012 Nov 29.

Abstract

The present study aims to estimate the biological doses received by five victims (A, B, C, D and E) of the Shanxi Taiyuan radiation accident in China of 2008 and to investigate the value of the cytokinesis-block micronuclei (CBMN) and premature chromosome condensation (PCC) assays in the estimation of biological doses received by the victims of a radiation accident. Conventional chromosome aberration analysis and the CBMN assay, as well as a drug-induced PCC assay recently established by our group, were performed on peripheral blood and bone marrow samples from five victims after the accident. The biological doses were estimated by scoring dicentrics plus centric rings, micronuclei and PCC rings. A high dose-effect curve and the nuclear division index (NDI) we previously established were used to estimate the dose received by victim A, the most highly affected victim of the five. The doses for the five victims (A, B, C, D and E) were 12.4, 3.4, 2.5, 2.1 and 2.2Gy, respectively, estimated by scoring dicentrics plus rings in peripheral blood lymphocytes. Similar results were obtained by combining the CBMN and NDI (CBMN+NDI) assays and the PCC assay. The doses estimated by the three methods were in accordance with the clinical symptoms observed. The specific dicentric assay with a low background level may be a better indicator for biological dose evaluation than the CBMN and PCC assays. The high dose curve we established is reliable and could become a suitable supplement to traditional biodosimetry for dose estimation. The CBMN and drug-induced PCC assays are simple, rapid and accurate. The two methods reinforce and verify the results observed with chromosome aberration analysis.

摘要

本研究旨在估算 2008 年中国山西太原辐射事故中 5 名受害者(A、B、C、D 和 E)所受的生物剂量,并探讨细胞有丝分裂阻断微核(CBMN)和早熟染色体凝聚(PCC)试验在估算辐射事故受害者生物剂量中的价值。事故发生后,我们对 5 名受害者的外周血和骨髓样本进行了常规染色体畸变分析、CBMN 试验以及我们最近建立的药物诱导 PCC 试验。通过分析双着丝粒加着丝粒环、微核和 PCC 环来估算生物剂量。我们之前建立的高剂量效应曲线和核分裂指数(NDI)用于估算受影响最严重的受害者 A 的剂量。通过分析外周血淋巴细胞中的双着丝粒加环,估算出 5 名受害者(A、B、C、D 和 E)的剂量分别为 12.4、3.4、2.5、2.1 和 2.2Gy,这与临床观察到的症状相符。通过结合 CBMN 和 NDI(CBMN+NDI)试验和 PCC 试验,也得到了类似的结果。三种方法估算的剂量与观察到的临床症状相符。低背景水平的特异性双着丝粒试验可能是生物剂量评估的更好指标,优于 CBMN 和 PCC 试验。我们建立的高剂量曲线是可靠的,可以成为传统生物剂量测定法的合适补充,用于剂量估算。CBMN 和药物诱导的 PCC 试验简单、快速、准确。这两种方法增强并验证了染色体畸变分析的结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验